ATAD1 is a mitochondrial AAA+ ATPase that serves as a critical quality control factor for protein homeostasis at the outer mitochondrial membrane. Its primary function involves ATP-dependent extraction of mislocalized tail-anchored transmembrane proteins from mitochondrial membranes, preventing their toxic accumulation and maintaining organellar integrity 1. The protein acts as a dislocase that recognizes and removes both mistargeted proteins and those clogged in the translocase of the outer membrane (TOM) complex, thereby clearing the mitochondrial protein import machinery 2. ATAD1 interacts directly with TOM and stalled proteins, with its knockout resulting in extensive accumulation of mitochondrial precursors and decreased protein import efficiency 2. Beyond mitochondrial quality control, ATAD1 regulates apoptosis by extracting the pro-apoptotic protein BIM from mitochondria to inactivate it 3. In disease contexts, ATAD1 downregulation correlates with poor prognosis in prostate adenocarcinoma and creates vulnerability to proteasome inhibitors in cancer cells lacking this protein 43. The protein's loss, often through co-deletion with PTEN on chromosome 10, sensitizes cancer cells to proteasome dysfunction-induced apoptosis, suggesting potential therapeutic applications 3. ATAD1 expression changes have also been implicated in Alzheimer's disease pathogenesis 5.